NexImmune Inc. Gains 31.06%

Thu, Mar 24, 2022 at 05:30 PM
NexImmune Inc. Gains 31.06%

NexImmune Inc. (NEXI:NASDAQ) soared at $3.46, representing a gain of 31.1%. On Wed, Mar 23, 2022, NEXI:NASDAQ touched a New 2-Week Intraday High of $2.82. The stock got featured on our News Catalysts scanner on Thu, Mar 17, 2022 at 08:02 AM in the 'PATNERSHIP' category. From Thu, Mar 10, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

About NexImmune Inc. (NEXI:NASDAQ)

NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.